Atea Pharmaceuticals, Inc. SEC filings AVIR
Atea Pharmaceuticals, Inc. has 313 filings in SEC EDGAR's recent list, going back to Dec 11, 2013. Its latest annual report, Form 10-K, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 18, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 8, 2026 | Jan 8, 2026 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2025 | Jun 20, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Officer or director change, Regulation FD disclosure
|
Apr 17, 2025 | Apr 16, 2025 |
| DEFA14A | Additional proxy material | Apr 3, 2025 | — |
| DEFA14A | Additional proxy material | Apr 1, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 1, 2025 | Mar 31, 2025 |
| DEFA14A | Additional proxy material | Mar 26, 2025 | — |
| DFAN14A | Filing | Mar 26, 2025 | — |
| DEFA14A | Additional proxy material | Mar 24, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 24, 2025 | Mar 21, 2025 |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 24, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 14, 2025 | Jan 13, 2025 |
| EFFECT | Filing | Nov 19, 2024 | — |
| CORRESP | Letter to the SEC | Nov 15, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2024 | — |
| S-3 | Shelf registration | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 21, 2024 |
| DEFA14A | Additional proxy material | Jun 4, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 21, 2024 |
| 10-K | Annual report | Feb 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 21, 2023 | Jun 16, 2023 |
| DEFA14A | Additional proxy material | Jun 12, 2023 | — |
| DEFA14A | Additional proxy material | May 25, 2023 | — |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| 10-Q | Quarterly report | Nov 7, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2022 | Jun 17, 2022 |
| EFFECT | Filing | May 12, 2022 | — |
| POS AM | Filing | May 10, 2022 | — |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 17, 2022 |
| POS AM | Filing | Mar 1, 2022 | — |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| POSASR | Filing | Feb 28, 2022 | — |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 26, 2021 | Nov 26, 2021 |
| S-3ASR | Automatic shelf registration | Nov 24, 2021 | — |
| 8-K |
Current report
Agreement ended
|
Nov 16, 2021 | Nov 12, 2021 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 11, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 23, 2021 | Jul 19, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Officer or director change
|
May 20, 2021 | May 18, 2021 |
| DEFA14A | Additional proxy material | May 20, 2021 | — |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 19, 2021 | Apr 15, 2021 |
| 10-K | Annual report | Mar 30, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Dec 10, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 5, 2020 | Nov 3, 2020 |
| S-8 | Employee stock plan registration | Oct 30, 2020 | — |
| 424B4 | Prospectus | Oct 30, 2020 | — |
| EFFECT | Filing | Oct 29, 2020 | — |
| S-1MEF | Filing | Oct 29, 2020 | — |
| CORRESP | Letter to the SEC | Oct 29, 2020 | — |
| CERT | 8a cert | Oct 28, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 27, 2020 | — |
| CORRESP | Letter to the SEC | Oct 27, 2020 | — |
| CORRESP | Letter to the SEC | Oct 27, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2020 | — |
| S-1/A | Amended registration statement | Oct 26, 2020 | — |
| 8-A12B | Filing | Oct 26, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 23, 2020 | — |
| S-1/A | Amended registration statement | Oct 23, 2020 | — |
| S-1 | Registration statement | Oct 9, 2020 | — |
| DRSLTR | Filing | Aug 7, 2020 | — |
| DRS/A | Filing | Aug 7, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2020 | — |
| DRS | Filing | Jun 19, 2020 | — |
| D | Filing | May 29, 2020 | — |
| D | Filing | Jul 16, 2018 | — |
| D | Filing | Sep 13, 2016 | — |
| D/A | Filing | Sep 17, 2014 | — |
| D/A | Filing | May 21, 2014 | — |
| D | Filing | Dec 11, 2013 | — |
Showing 121 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AVIR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1593899
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.